The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
New analyses, including presentations on mavacamten, apixaban and milvexian, further solidify the company's strength and expertise as a leader in cardiovascular diseases
The academy has secured partnerships with 15 esteemed hospitals
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
Establishment of 220 smart classrooms across Uttar Pradesh, Uttarakhand, and Himachal Pradesh
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
Subscribe To Our Newsletter & Stay Updated
